Chronic high-dose creatine feeding does not attenuate left ventricular remodeling in rat hearts post-myocardial infarction

Cardiovascular Research

Volumn 43, Issue 1, 1999, Pages 117-124

  Horn, Michael ^a   Remkes, Helga ^a   Dienesch, Charlotte ^a   Hu, Kai ^b   Ertl, Georg ^b   Neubauer, Stefan ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

31P NMR spectroscopy; ATP; Creatine; Heart failure; Isolated rat heart; Phosphocreatine

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE; CREATINE PHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DIETARY INTAKE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME MECHANISM; FEEDING; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; INSPIRATORY RESERVE VOLUME; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT; STEADY STATE;

ADENOSINE TRIPHOSPHATE; ADMINISTRATION, ORAL; ANIMALS; CREATINE; HEART FAILURE, CONGESTIVE; MAGNETIC RESONANCE SPECTROSCOPY; MYOCARDIAL INFARCTION; MYOCARDIUM; PERFUSION; PHOSPHOCREATINE; RATS; RATS, WISTAR; VENTRICULAR REMODELING;

EID: 0033001346     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00075-9     Document Type: Article

References (33)

1. Neubauer S., Horn M., Naumann A., et al. Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction. J Clin Invest. 95:1995;1092-1100.
2. Nascimben L., Friedrich J., Liao R., Pauletto P., Pessina A.C., Ingwall J.S. Enalapril treatment increases cardiac performance and energy reserve via the creatine kinase reaction in myocardium of Syrian myopathic hamsters with advanced heart failure. Circulation. 91:1995;1824-1833.
3. 31P MRS study. Circulation. 94:1996;1089-1100.
4. Ingwall J.S., Kramer M.F., Fifer M.A., et al. The creatine kinase system in normal and diseased human myocardium. N Engl J Med. 313:1985;1050-1054.
5. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation. 86:1992;1810-1818.
6. Nascimben L., Ingwall J.S., Pauletto P., et al. The creatine kinase system in failing and nonfailing human myocardium. Circulation. 94:1996;1894-1901.
7. Hardy C.J., Weiss R.G., Bottomley P.A., Gerstenblith G. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J. 122:1991;795-801.
8. Liao R., Nascimben L., Friedrich J., Gwathmey J.K., Ingwall J.S. Decreased energy reserve in an animal model of dilated cardiomyopathy. Relationship to contractile performance. Circ Res. 78:1996;893-902.
9. Ingwall J.S. Is cardiac failure a consequence of decreased energy reserve? Circulation. 87:(Suppl. VII):1993;58-62.
10. Laser A., Neubauer S., Tian R., et al. Long-term beta-blocker treatment prevents chronic creatine kinase and lactate dehydrogenase system changes in rat hearts post-myocardial infarction. J Am Coll Cardiol. 27:1996;487-493.
11. Horn M., Neubauer S., Frantz S., et al. Preservation of left ventricular mechanical function and energy metabolism in rats post myocardial infarction by the angiotensin converting enzyme inhibitor Quinapril. J Cardiovasc Pharmacol. 27:1996;201-210.
12. +-dependent creatine transporter in rabbit brain, muscle, heart and kidney. J Biol Chem. 268/12:1993;8418-8421.
13. Harris R.C., Söderlund K., Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci. 83:1992;367-374.
14. Greenhaff P. Creatine and its application as an ergogenic aid. Int J Sport Nutr. 5:1995;S100-S110.
15. Horn M., Frantz S., Remkes H., et al. Effects of chronic dietary creatine feeding on cardiac energy metabolism and on creatine content in heart, skeletal muscle, brain, liver and kidney. J Mol Cell Cardiol. 30:1998;277-284.
16. Laser A., Ingwall J.S., Tian R., et al. Regional biochemical remodeling in non-infarcted tissue of rat heart post-myocardial infarction. J Mol Cell Cardiol. 28:1996;1531-1538.
17. Neubauer S., Ertl G., Haas U., Pulzer F., Kochsiek K. Effects of endothelin-1 in the isolated perfused rat heart. J Cardiovasc Pharmacol. 16:1990;1-8.
18. Illing B., Horn M., Han H., et al. Protective effect of the specific endothelin-1 antagonist BQ610 on mechanical function and energy metabolism during ischemia/reperfusion injury in isolated perfused rat hearts. J Cardiovasc Pharmacol. 27:1996;487-494.
19. 31P magnetic resonance. J Biol Chem. 248:1973;7276-7278.
20. Forsen S., Hofman R.A. Study of moderately rapid chemical exchange reactions by means of nuclear magnetic double resonance. J Chem Phys. 39:1963;2892-2901.
21. 31P NMR studies of the isolated rat heart. J Mol Cell Cardiol. 21:1989;1163-1178.
22. Lowry O.H., Rosebrough M.J., Farr A.L., Randall R.J. Protein measurement with the Folin reagent. J Biol Chem. 193:1951;265.
23. 31P NMR spectroscopic study of the isovolumic rat heart. NMR Biomed. 6:1993;278-286.
24. Kammermeier H., Schmidt P., Jüngling E. Free energy change of ATP-hydrolysis: A causal factor of early hypoxic failure of the myocardium? J Mol Cell Cardiol. 14:1982;267-277.
25. Zar J.H. Biostatistical analysis. 1974;130-181 Prentice Hall, Englewood Cliffs, NJ.
26. Tian R., Gaudron P., Neubauer S., Hu K., Ertl G. Alterations of performance and oxygen utilization in chronically infarcted rat hearts. J Mol Cell Cardiol. 28:1995;321-330.
27. Gaudron P., Hu K., Schamberger R., Budin M., Walter B., Ertl G. Effect of endurance training early or late after coronary occlusion on left ventricular remodeling, hemodynamics, and survival in rats with chronic transmural myocardial infarction. Circulation. 89:1994;402-412.
28. Horn M., Neubauer S., Frantz S., et al. Preservation of left ventricular mechanical function and energy metabolism in rats after myocardial infarction by the angiotensin-converting enzyme inhibitor quinapril. J Cardiovasc Pharmacol. 27:1996;201-210.
29. Wyss M., Wallimann T. Creatine metabolism and the consequences of creatine depletion in muscle. Mol Cell Biochem. 133/134:1994;51-66.
30. Ferraro S., Maddelena G., Fazio S., et al. Acute and short-term efficiency of high doses of creatine phosphate in the treatment of heart failure. Curr Ther Res. 47:1990;917-923.
31. Scattolin G., Gabellini A., Desideri A., Formichi M., Caneve F., Corbara F. Diastolic function and creatine phosphate: an echocardiographic study. Curr Ther Res. 54:1993;562-571.
32. Odoom J.E., Kemp G.J., Radda G.K. The regulation of total creatine content in a myoblast cell line. Mol Cell Biochem. 158:1996;179-188.
33. Loike J.D., Zalutsky D.L., Kaback E., Miranda A.F., Silverstein S.C. Extracellular creatine regulates creatine transport in rat and human muscle cells. Proc Natl Acad Sci USA. 85:1988;807-811.